| Name | 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
|---|---|
| Synonyms |
1-N-ethyl CNS
1H-1,2,4-Triazole,1-ethyl N-ethyl-1,2,4-triazole 1-N-ethyl 1,2,4-triazole 1H-1-Ethyl Candesartan Cilexetil Candesartan Cilexetil Impurity 5 |
| Description | 1H-1-Ethyl Candesartan Cilexetil is a potential impurity found in bulk preparations of Candesartan Cilexetil (HY-17505). |
|---|---|
| Related Catalog |
| Molecular Formula | C35H38N6O6 |
|---|---|
| Molecular Weight | 638.71300 |
| Exact Mass | 638.28500 |
| PSA | 132.48000 |
| LogP | 6.81240 |
|
~%
914613-35-7 |
| Literature: Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362 |
|
~%
914613-35-7 |
| Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |